September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Paolo Tarantino Highlights Positive PFS Results from DYNASTY-Breast02 Trial
Sep 7, 2025, 12:21

Paolo Tarantino Highlights Positive PFS Results from DYNASTY-Breast02 Trial

Paolo Tarantino, 2025 Yvonne’s “Top Voice” Award Winner, Associate Editor for Breast Cancer at ESMO Open, shared a post on X:

“Press release: positive PFS results from a Chinese phase 3 trial comparing Trastuzumab Pamirtecan (BNT323/DB-1303 – quite similar to T-DXd) to T-DM1 for HER2+ MBC. The DYNASTY-Breast02 trial is testing BNT323 as 1st cytotoxic therapy for HER2-low disease.”

Read the Full Article in BIOTECH.

Paolo Tarantino

More posts featuring Trastuzumab on OncoDaily.